Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02519790 · ClinicalTrials.gov registry record
Optimizing Medication Management for Mothers With Depression
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 88
- Enrollment target
NCT02519790: Completed study, sponsored by Northwestern University.
NCT02519790 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02519790 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the way the antidepressant concentration (amount of medication) in the blood changes due to the physiological changes in the body (i.e., changes in metabolism, hormones and body fluid) during pregnancy and postpartum and the impact of genetic factors on the degree of these changes. Changes in antidepressant concentration are important to monitor, as decreases in antidepressant concentration may lead to less than therapeutic drug levels, which may cause an increase in mood symptoms or recurrence of depressive episodes. Increases in antidepressant concentration have the potential to lead to increased side effects. The study team is hoping to better understand the course of these changes across pregnancy and postpartum and how an individual's genetic makeup impacts these changes with the goal of developing guidelines to optimize antidepressant treatment of pregnant women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2016-08 |
| Est. Completion | 2021-06-30 |
What the finished NCT02519790 record still lists
NCT02519790 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02519790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02519790 about?
NCT02519790 is a clinical study titled "Optimizing Medication Management for Mothers With Depression". The purpose of this study is to explore the way the antidepressant concentration (amount of medication) in the blood changes due to the physiological changes in the body (i.e., changes in metabolism, hormones and body fluid) during pregnancy and postpartum and the impact of genetic factors on the de...
What is the current status of trial NCT02519790?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2016-08. Estimated completion is 2021-06-30.
Who is sponsoring clinical trial NCT02519790?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia